Mainboard IPO Listing estimate

The Live listing estimates for Mainboard IPOs, provided below can be highly useful for investors. They help you plan in advance whether to hold, book listing gains, or exit the allotted shares. A careful look at these estimates will enable you to make informed and timely decisions on the listing day.

👉Corona Remedies IPO – Listing Estimate (Listing on 15 December 2025)

The IPO witnessed an extraordinary overall subscription of 144.54×, driven by massive institutional and HNI participation.
QIB demand at 293.80× and combined HNI subscription of 220.18× clearly indicate strong smart-money and leveraged interest.
Retail participation at 30.39× also reflects broad-based confidence in the issue despite the high ticket size.
A total of 41,87,186 applications were received, translating into an average application amount of around Rs. 295,906, indicating concentrated big-ticket bets.
Net of anchor investors, 43,36,298 shares worth Rs. 460.51 Cr were offered, making this one of the most aggressively chased issues in recent times.
With an issue price of Rs. 1,065 and the latest GMP at Rs. 295, grey market cues remain extremely firm.
Based on current trends and demand intensity, the listing price is estimated in the range of Rs. 1,350–1,370, subject to last-day sentiment.

👉Wakefit IPO – Listing Estimate (Listing on 15 December 2025)

Wakefit IPO closed with an overall subscription of 2.52×, indicating decent but not aggressive demand across categories.
Retail interest remained healthy at 3.17×, while QIB participation at 3.04× provided reasonable institutional support.
HNI demand stayed muted at 1.05×, reflecting limited leverage-driven enthusiasm at current valuation.
With 2,33,012 applications received, the response suggests steady interest rather than speculative frenzy.
The issue price is Rs. 195, and the latest grey market premium (GMP) stands at Rs. 4. Overall, Wakefit IPO is expected to see a near-cost to marginally positive listing ( Rs. 195/200), barring sharp last-minute GMP movement.

👉Meesho IPO – Listing Estimate (Listing on 10 December 2025)

Meesho’s Rs. 5,421.20 crore IPO has witnessed exceptionally strong institutional support, with QIB subscription at 123.34 times—far superior to the HNI and Retail categories. This indicates solid conviction from long-term institutional investors and reduces the risk of heavy selling pressure on listing day.

Although the company has reported losses over the last three years, investors have clearly taken comfort from the sharp surge in topline growth and significant improvement in EBIT performance, reflecting operational strength and scalability in its asset-light business model.

Given the overall subscription profile, strong QIB backing, and improving financial trajectory, the shares are expected to list in the range of:

👉 Rs. 140 to Rs. 142

A stable-to-positive listing is anticipated, backed by institutional demand.

Aequs IPO – Listing Estimate (Listing: 10 December 2025)

Aequs IPO has witnessed overall blockbuster demand, with total subscription crossing 104 times, reflecting strong appetite across all categories. Retail and HNI participation is extremely high, with HNIs at 83.61x and Retail at 81.03x, which indicates significant selling pressure on listing day as leveraged positions unwind.

However, the most important factor is the robust QIB subscription of 122.93x, clearly signalling strong institutional conviction. QIB strength typically absorbs selling pressure and provides stability, especially in companies with high-growth potential.

Despite losses in the last three years—making PE calculations irrelevant—the company’s topline momentum, niche precision manufacturing portfolio, and reasonable offer valuation leave ample room for both listing gains and post-listing appreciation. The prevailing GMP of Rs. 28 over the issue price of Rs. 124 also supports a premium opening.

Expected Listing Range

Rs. 160 – Rs. 165 per share, with a higher probability of listing near the upper band, given institutional demand and sector fancy.

Post-Listing Outlook

Long-term investors may consider retaining the stock, as the business has solid 9–12 months growth potential and operates in a sector where valuations can rerate meaningfully.

Vidya Wires IPO – Refined Listing Estimate (Listing: 10 December 2025)

Vidya Wires IPO has witnessed strong interest across investor categories, particularly from HNIs (55.94×) and Retail (29.98×). Such heavy oversubscription from leveraged categories typically brings substantial selling pressure on listing day. However, the presence of QIB subscription at 5.45× provides stability and reduces extreme volatility risk.

Fundamentally, the company stands on solid ground. With backward integration, a broad customer base and established industry relationships, the business enjoys operational stability and lower concentration risk. Its valuation at a PE of 20.36 is reasonable for the segment, leaving potential room for healthy listing gains. The profitability ratios—ROE at 24.57% and ROCE at 19.72%—underscore efficient operations, though margins remain modest in line with manufacturing businesses.

The grey market premium of Rs. 4 supports mild listing positivity.

Expected Listing Price Range

Rs. 55 to Rs. 60 per share, with higher probability toward the upper end of the range due to fair valuations and strong participation from all categories.

Investors with a 9–12 months horizon may see better returns, as the company’s fundamentals and industry positioning remain favourable for medium-term appreciation.

• Review
• Research Reports
• Paid Calls
• Sahifund.com